Ladiratuzumab vedotin

Ladiratuzumab vedotin (SGN-LIV1A, Anti-LIV-1 ADC) is an antibody-drug conjugate (ADC) composed of humanized anti-LIV-1 antibody, conjugated to Monomethyl auristatin E (MMAE), via a proteolytically cleavable type linker. Ladiratuzumab vedotin has the potential for use in multiple carcinomas.

Price Not Available 1mg*5 Ladiratuzumab vedotin Supplier Page

Trivial name	SGN-LIV1A, Anti-LIV-1 ADC
Catalog Number	D4057
Molecular Formula	4.16
Size	1mg*5
Supplier Page	http://www.selleckchem.com/products/ladiratuzumab-vedotin.html